Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Influenza, Human 13Neoplasms 6Colorectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Recurrence 2Pancreatic Neoplasms 2Neuroblastoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Virus Diseases 1Vaccine-Preventable Diseases 1Vaccination Hesitancy 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Patient Acceptance of Health Care 1Ovarian Neoplasms 1Osteosarcoma 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 3Oncolytic Virotherapy 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Bevacizumab 2valrubicin 1thymoglobulin 1ledipasvir, sofosbuvir drug combination 1hepatitis C immune globulin, human 1halofantrine 1VP-102 1Therapies, Investigational 1Tenofovir 1Rituximab 1Radiotherapy, Intensity-Modulated 1Papillomavirus Vaccines 1Nimorazole 1Mitomycin 1Lamivudine 1Kidney Transplantation 1Ipilimumab 1Interferons 1Influenza Vaccines 1Immunoglobulin G 1Imiquimod 1Gemcitabine 1Gels 1Fluorescent Antibody Technique 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Virus Diseases × Influenza Vaccines × Clear all
NCT01031719 2012-09-13

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors

Chiltern Pesquisa Clinica Ltda

Phase 3 Completed
59 enrolled

Influenza, Human, Neoplasms, Virus Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡